Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
- PMID: 21865317
- DOI: 10.1096/fj.10-179192
Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
Abstract
Parkinson's disease (PD) is characterized by the presence of Lewy bodies containing phosphorylated and aggregated α-synuclein (α-syn). α-Syn is present in human body fluids, including blood plasma, and is a potential biomarker for PD. Immunoassays for total and oligomeric forms of both normal and phosphorylated (at Ser-129) α-syn have been used to assay plasma samples from a longitudinal cohort of 32 patients with PD (sampled at mo 0, 1, 2, 3), as well as single plasma samples from a group of 30 healthy control participants. The levels of α-syn in plasma varied greatly between individuals, but were remarkably consistent over time within the same individual with PD. The mean level of phospho-α-syn was found to be higher (P=0.053) in the PD samples than the controls, whereas this was not the case for total α-syn (P=0.244), oligo-α-syn (P=0.221), or oligo-phospho-α-syn (P=0.181). Immunoblots of plasma revealed bands (at 21, 24, and 50-60 kDa) corresponding to phosphorylated α-syn. Thus, phosphorylated α-syn can be detected in blood plasma and shows more promise as a diagnostic marker than the nonphosphorylated protein. Longitudinal studies undertaken over a more extended time period will be required to determine whether α-syn can act as a marker of disease progression.
Similar articles
-
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.FASEB J. 2006 Mar;20(3):419-25. doi: 10.1096/fj.03-1449com. FASEB J. 2006. PMID: 16507759
-
Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment.Mov Disord. 2010 Mar 15;25(4):489-93. doi: 10.1002/mds.22928. Mov Disord. 2010. PMID: 20063406
-
Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.Neurosci Lett. 2015 Jul 10;599:115-9. doi: 10.1016/j.neulet.2015.05.030. Epub 2015 May 18. Neurosci Lett. 2015. PMID: 25998655
-
Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies.Biomark Med. 2010 Oct;4(5):683-99. doi: 10.2217/bmm.10.90. Biomark Med. 2010. PMID: 20945981 Review.
-
Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.Mov Disord. 2014 Apr;29(4):444-50. doi: 10.1002/mds.25789. Epub 2013 Dec 26. Mov Disord. 2014. PMID: 24375496 Review.
Cited by
-
Αlpha-synuclein levels in blood plasma from LRRK2 mutation carriers.PLoS One. 2012;7(12):e52312. doi: 10.1371/journal.pone.0052312. Epub 2012 Dec 27. PLoS One. 2012. PMID: 23300640 Free PMC article.
-
A new approach: information gain algorithm-based k-nearest neighbors hybrid diagnostic system for Parkinson's disease.Phys Eng Sci Med. 2021 Jun;44(2):511-524. doi: 10.1007/s13246-021-01001-6. Epub 2021 Apr 14. Phys Eng Sci Med. 2021. PMID: 33852120
-
α-Synuclein Interacts with Lipoproteins in Plasma.J Mol Neurosci. 2017 Oct;63(2):165-172. doi: 10.1007/s12031-017-0967-0. Epub 2017 Sep 8. J Mol Neurosci. 2017. PMID: 28887769 Free PMC article.
-
Blood-based biomarkers for Parkinson's disease.Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1(0 1):S99-103. doi: 10.1016/S1353-8020(13)70025-7. Parkinsonism Relat Disord. 2014. PMID: 24262199 Free PMC article. Review.
-
Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction.Brain. 2020 Jun 1;143(6):1780-1797. doi: 10.1093/brain/awaa110. Brain. 2020. PMID: 32428221 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous